Androgens and ovarian function: translation from basic discovery research to clinical impact K Walters, VR Paris, A Aflatounian, DJ Handelsman Journal of Endocrinology 1 (aop), 2019 | 84 | 2019 |
Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model A Aflatounian, MC Edwards, VR Paris, MJ Bertoldo, R Desai, RB Gilchrist, ... Journal of Endocrinology 245 (3), 381-395, 2020 | 75 | 2020 |
Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model MJ Cox, MC Edwards, V Rodriguez Paris, A Aflatounian, WL Ledger, ... Endocrinology 161 (7), bqaa061, 2020 | 61 | 2020 |
Perinatal outcome in fresh versus frozen embryo transfer in ART cycles A Aflatoonian, MAK Maybodi, N Aflatoonian, N Tabibnejad, ... International Journal of Reproductive BioMedicine 14 (3), 167, 2016 | 48 | 2016 |
Maternal metabolic factors and the association with gestational diabetes: a systematic review and meta‐analysis N Habibi, A Mousa, CT Tay, MB Khomami, RK Patten, PH Andraweera, ... Diabetes/Metabolism Research and Reviews 38 (5), e3532, 2022 | 34 | 2022 |
The interplay between PCOS pathology and diet on gut microbiota in a mouse model V Rodriguez Paris, XYD Wong, SM Solon-Biet, MC Edwards, ... Gut Microbes 14 (1), 2085961, 2022 | 33 | 2022 |
Neurokinin 3 receptor antagonism ameliorates key metabolic features in a hyperandrogenic PCOS mouse model IE Sucquart, R Nagarkar, MC Edwards, V Rodriguez Paris, A Aflatounian, ... Endocrinology 162 (5), bqab020, 2021 | 29 | 2021 |
Pathogenesis of reproductive and metabolic PCOS traits in a mouse model V Rodriguez Paris, MC Edwards, A Aflatounian, MJ Bertoldo, WL Ledger, ... Journal of the Endocrine Society 5 (6), bvab060, 2021 | 20 | 2021 |
Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation A Aflatounian, VR Paris, D Richani, MC Edwards, BJ Cochran, WL Ledger, ... Molecular Metabolism 65, 101583, 2022 | 16 | 2022 |
Does adding adverse pregnancy outcomes improve the Framingham Cardiovascular Risk Score in women? Data from the Tehran Lipid and Glucose Study M Saei Ghare Naz, A Sheidaei, A Aflatounian, F Azizi, ... Journal of the American Heart Association 11 (2), e022349, 2022 | 12 | 2022 |
Chronic niacin administration ameliorates ovulation, histological changes in the ovary and adiponectin concentrations in a rat model of polycystic ovary syndrome N Asadi, M Izadi, A Aflatounian, M Esmaeili-Dehaj, ME Rezvani, Z Hafizi Reproduction, Fertility and Development 33 (7), 447-454, 2021 | 6 | 2021 |
Adolescents’ polycystic ovary syndrome health-related quality of life questionnaire (APQ-20): development and psychometric properties M Saei Ghare Naz, G Ozgoli, F Ahmadi, H Alavi Majd, A Aflatounian, ... European Journal of Pediatrics 182 (5), 2393-2407, 2023 | 3 | 2023 |
Pharmacological Antagonism of the Kisspeptin-Neurokinin System Improved Adverse Metabolic Traits in a PCOS Mouse Model IE SUCQUART, R NAGARKAR, MC EDWARDS, VR PARIS, ... Fertility & Reproduction 4 (03n04), 160-160, 2022 | | 2022 |
Mitochondrial Uncoupler BAM15 Ameliorates Associated Metabolic PCOS Traits in a Hyperandrogenic PCOS Mouse Model V RODRIGUEZ PARIS, SJ ALEXOPOULOS, Y HU, DP SHAH, ... Fertility & Reproduction 4 (03n04), 208-208, 2022 | | 2022 |
Polycystic Ovary Syndrome: Mechanisms of Development and Novel Treatments A Aflatounian UNSW Sydney, 2021 | | 2021 |